1
Views
3
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Overexpression of C-Terminally but Not N-Terminally Truncated Myb Induces Fibrosarcomas: a Novel Nonhematopoietic Target cell for the myb Oncogene

, &
Pages 2278-2290 | Received 25 Aug 1993, Accepted 24 Nov 1993, Published online: 30 Mar 2023

REFERENCES

  • al Moustafa, A. E., B. Quatannens, F. Dieterlen Lievre, and S. Saule. 1992. Tumorigenic effects mediated in the avian embryo by one or more oncogenes associated with v-myc. Oncogene 7:1667–1670.
  • Anfossi, G., A. M. Gewirtz, and B. Calabretta. 1989. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc. Natl. Acad. Sci. USA 86:3379–3383.
  • Bader, D., T. Masaki, and D. A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763–770.
  • Bading, H., J. Hansen, and K. Moelling. 1987. Selective DNA binding of the human cellular myb protein isolated by immunoaf-finity chromatography using a monoclonal antibody. Oncogene 1:395–401.
  • Clarke, M. F., J. F. Kukowska-Latallo, E. Westin, M. Smith, and E. V. Prochownik. 1988. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8:884–892.
  • Cogswell, J. P., P. C. Cogswell, W. M. Kuehl, A. M. Cuddihy, T. M. Bender, U. Engelke, K. B. Marcu, and J. P. Ting. 1993. Mechanism of c-myc regulation by c-Myb in different cell lineages. Mol. Cell. Biol. 13:2858–2869.
  • Craig, R. W., and A. Bloch. 1984. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-Otetradecanoylphorbol-13-acetate. Cancer Res. 44:442–446.
  • Danto, S. I., and D. A. Fischman. 1984. Immunocytochemical analysis of intermediate filaments in embryonic heart cells with monoclonal antibodies to desmin. J. Cell Biol. 98:2179–2191.
  • Evan, G. I., G. K. Lewis, and J. M. Bishop. 1984. Isolation of monoclonal antibodies specific for products of avian oncogene myb. Mol. Cell. Biol. 4:2843–2850.
  • Evans, J. L., T. L. Moore, W. M. Kuehl, T. Bender, and J. P. Ting. 1990. Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter. Mol. Cell. Biol. 10:5747–5752.
  • Ewert, D. L., N. Avdalovic, and C. Goldstein. 1989. Follicular exclusion of retroviruses in the bursa of Fabricius. Virology 170:433–441.
  • Foellmer, H. G., K. Kawahara, J. A. Madri, H. Furthmayr, R. Timpl, and L. Tuderman. 1983. A monoclonal antibody specific for the amino terminal cleavage site of procollagen type I. Eur. J. Biochem. 134:183–189.
  • Frampton, J., A. Leutz, T. Gibson, and T. Graf. 1989. DNA-binding domain ancestry. Nature (London) 342:134. (Letter.)
  • Garrido, C., F. Grasser, J. S. Lipsick, D. Stehelin, and S. Saule. 1992. Protein truncation is not required for c-myb proto-oncogene activity in neuroretina cells. J. Virol. 66:6773–6776.
  • Gerondakis, S., and J. M. Bishop. 1986. Structure of the protein encoded by the chicken proto-oncogene c-myb. Mol. Cell. Biol. 6:3677–3684.
  • Gewirtz, A. M., G. Anfossi, D. Venturelli, S. Valpreda, R. Sims, and B. Calabretta. 1989. G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 245:180–183.
  • Gonda, T. J., C. Buckmaster, and R. G. Ramsay. 1989. Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro. EMBO J. 8:1777–1783.
  • Gonda, T. J., N. M. Gough, A. R. Dunn, and J. de Blaquiere. 1985. Nucleotide sequence of cDNA clones of the murine myb proto-oncogene. EMBO J. 4:2003–2008.
  • Gonda, T. J., and D. Metcalf. 1984. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature (London) 310:249–251.
  • Grasser, F. A., T. Graf, and J. S. Lipsick. 1991. Protein truncation is required for the activation of the c-myb proto-oncogene. Mol. Cell. Biol. 11:3987–3996.
  • Hu, Y. L., R. G. Ramsay, C. Kanei Ishii, S. Ishii, and T. J. Gonda. 1991. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 6:1549–1553.
  • Hughes, S. H. 1982. Sequence of the long terminal repeat and adjacent segments of the endogenous avian virus Rous-associated virus O. J. Virol. 43:191–200.
  • Hughes, S. H., J. J. Greenhouse, C. J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61:3004–3012.
  • Humphries, E. H., M. L. Danhof, and I. Hlozanek. 1984. Characterization of endogenous viral loci in five lines of white leghorn chickens. Virology 135:125–138.
  • Introna, M., J. Golay, J. Frampton, T. Nakano, S. A. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of my-elomonocytic cells transformed by the oncogene. Cell 63:1289–1297.
  • Kanei Ishii, C., E. M. MacMillan, T. Nomura, A. Sarai, R. G. Ramsay, S. Aimoto, S. Ishii, and T. J. Gonda. 1992. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. USA 89:3088–3092.
  • Kanter, M. R., R. E. Smith, and W. S. Hayward. 1988. Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J. Virol. 62:1423–1432.
  • Klempnauer, K. H., T. J. Gonda, and J. M. Bishop. 1982. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31:453–463.
  • Klempnauer, K. H., G. Ramsay, J. M. Bishop, M. G. Moscovici, C. Moscovici, J. P. McGrath, and A. D. Levinson. 1983. The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell 33:345–355.
  • Klempnauer, K. H., and A. E. Sippel. 1987. The highly conserved amino-terminal region of the protein encoded by the v-myb oncogene functions as a DNA-binding domain. EMBO J. 6:2719–2725.
  • Kryceve Martinerie, C., J. Soret, J. Crochet, M. Baluda, and B. Perbal. 1987. Expression of a truncated v-myb product in transformed chicken embryo fibroblasts. FEBS Lett. 214:81–86.
  • Ku, D. H., S. C. Wen, A. Engelhard, N. C. Nicolaides, K. E. Lipson, T. A. Marino, and B. Calabretta. 1993. c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene. J. Biol. Chem. 268:2255–2259. (Erratum, 268: 13010.)
  • Levy, J. B., H. Iba, and H. Hanafusa. 1986. Activation of the transforming potential of p60c-src by a single amino acid change. Proc. Natl. Acad. Sci. USA 83:4228–4232.
  • Luscher, B., E. Christenson, D. W. Litchfield, E. G. Krebs, and R. N. Eisenman. 1990. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature (London) 344:517–522.
  • McMahon, J., K. M. Howe, and R. J. Watson. 1988. The induction of Friend erythroleukemia virus differentiation is markedly affected by expression of a transfected c-myb cDNA. Oncogene 3:717–720.
  • Melani, C., L. Rivoltini, G. Parmiani, B. Calabretta, and M. P. Colombo. 1991. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res. 51:2897–2901.
  • Merzak, A., Y. Dooghe, M. Pironin, B. Perbal, and P. Vigier. 1992. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts. Oncogene 7:2031–2039.
  • Metz, T., and T. Graf. 1991. Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus. Cell 66:95–105.
  • Michelin, S., I. Varlet, C. Martinerie, B. Perbal, A. Sarasin, and H. G. Suarez. 1991. v-myb transformation of xeroderma pigmentosum human fibroblasts: overexpression of the c-Ha-ras oncogene in the transformed cells. Exp. Cell Res. 196:314–322.
  • Mucenski, M. L., K. McLain, A. B. Kier, S. H. Swerdlow, C. M. Schreiner, T. A. Miller, D. W. Pietryga, W. J. J. Scott, and S. S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677–689.
  • Mukhopadhyaya, R., and L. Wolff. 1992. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J. Virol. 66: 6035–6044. (Erratum, 67:2960, 1993.)
  • Nicolaides, N. C., R. Gualdi, C. Casadevall, L. Manzella, B. Calabretta, K. Reiss, S. Travali, and R. Baserga. 1991. Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J. Cell. Physiol. 148:338–343.
  • O'Guin, W. M., L. W. Knapp, and R. H. Sawyer. 1982. Biochemical and immunohistochemical localization of alpha and beta keratin in avian scutate scales. J. Exp. Zool. 220:371–376.
  • Olson, W. C., and D. L. Ewert. 1990. Markers of B lymphocyte differentiation in the chicken. Hybridoma 9:331–350.
  • Pizer, E., and E. H. Humphries. 1989. RAV-1 insertional mutagenesis: disruption of the c-myb locus and development of avian B-cell lymphomas. J. Virol. 63:1630–1640.
  • Pizer, E. S., T. W. Baba, and E. H. Humphries. 1992. Activation of the c-myb locus is insufficient for the rapid induction of disseminated avian B-cell lymphoma. J. Virol. 66:512–523.
  • Press, R. D., and D. L. Ewert. Unpublished data.
  • Press, R. D., A. Kim, D. L. Ewert, and E. P. Reddy. 1992. Transformation of chicken myelomonocytic cells by a retrovirus expressing the v-myb oncogene from the long terminal repeats of avian myeloblastosis virus but not Rous sarcoma virus. J. Virol. 66:5373–5383.
  • Ramsay, R. G., S. Ishii, and T. J. Gonda. 1991. Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb. Oncogene 6:1875–1879.
  • Raschella, G., A. Negroni, T. Skorski, S. Pucci, M. Nieborowska Skorska, A. Romeo, and B. Calabretta. 1992. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines. Cancer Res. 52:4221–4226.
  • Reiss, K., A. Ferber, S. Travali, P. Porcu, P. D. Phillips, and R. Baserga. 1991. The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism. Cancer Res. 51:5997–6000.
  • Rosson, D. 1990. Effects of 5′ and 3′ truncations of the myb gene on the transforming ability of avian myeloblastosis virus (AMV). Virology 175:562–567.
  • Rosson, D., and E. P. Reddy. 1986. Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation. Nature (London) 319:604–606.
  • Saikumar, P., R. Murali, and E. P. Reddy. 1990. Role of tryptophan repeats and flanking amino acids in Myb-DNA interactions. Proc. Natl. Acad. Sci. USA 87:8452–8456.
  • Sainte-Marie, G. 1962. A paraffin embedding technique for studies employing immunofluorescence. J. Histochem. Cytochem. 10:250–253.
  • Sakura, H., C. Kanei Ishii, T. Nagase, H. Nakagoshi, T. J. Gonda, and S. Ishii. 1989. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. USA 86:5758–5762.
  • Schuur, E. R., and M. A. Baluda. 1991. Expression of MYB proteins in avian hematopoietic tissues. Oncogene 6:1923–1929.
  • Selvakumaran, M., D. A. Liebermann, and B. Hoffman-Liebermann. 1992. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis. Mol. Cell. Biol. 12:2493–2500.
  • Shen Ong, G. L., M. Potter, J. F. Mushinski, S. Lavu, and E. P. Reddy. 1984. Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas. Science 226:1077–1080.
  • Shen-Ong, G. L., and L. Wolff. 1987. Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice: requirement of c-myb activation but lack of v-abl involvement. J. Virol. 61:3721–3725.
  • Simons, M. L., E. R. Edelman, J. L. DeKeyser, R. Langer, and R. D. Rosenberg. 1992. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (London) 359:67–70.
  • Simons, M., and R. D. Rosenberg. 1992. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ. Res. 70:835–843.
  • Skalli, O., P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen, and G. Gabbiani. 1986. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103:2787–2796.
  • Soret, J., C. Kryceve Martinerie, J. Crochet, and B. Perbal. 1985. Transformation of brown leghorn chicken embryo fibroblasts by avian myeloblastosis virus proviral DNA. J. Virol. 55:193–205.
  • Tsukada, T., D. Tippens, D. Gordon, R. Ross, and A. M. Gown. 1987. HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am. J. Pathol. 126:51–60.
  • Weinstein, Y., J. N. Ihle, S. Lavu, and E. P. Reddy. 1986. Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line. Proc. Natl. Acad. Sci. USA 83:5010–5014.
  • Westin, E. H., R. C. Gallo, S. K. Arya, A. Eva, L. M. Souza, M. A. Baluda, S. A. Aaronson, and F. Wong Staal. 1982. Differential expression of the amv gene in human hematopoietic cells. Proc. Natl. Acad. Sci. USA 79:2194–2198.
  • Weston, K., and J. M. Bishop. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58:85–93.
  • Zobel, A., F. Kalkbrenner, S. Guehmann, M. Nawrath, G. Vorbrueggen, and K. Moelling. 1991. Interaction of the v- and c-Myb proteins with regulatory sequences of the human c-myc gene. Oncogene 6:1397–1407.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.